首页 | 本学科首页   官方微博 | 高级检索  
   检索      


High‐level expression of ARID1A predicts a favourable outcome in triple‐negative breast cancer patients receiving paclitaxel‐based chemotherapy
Authors:Yuan‐Feng Lin  Ing‐Jy Tseng  Chih‐Jung Kuo  Hui‐Yu Lin  I‐Jen Chiu  Hui‐Wen Chiu
Institution:1. Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan;2. School of Gerontology Healthy Management, College of Nursing, Taipei Medical University, Taipei, Taiwan;3. Department of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan;4. Division of Breast Surgery and General Surgery, Department of Surgery, Cardinal Tien Hospital, Xindian District, New Taipei City, Taiwan;5. Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan
Abstract:
Keywords:   ARID1A     chemotherapy  p38MAPK  paclitaxel  triple‐negative breast cancer
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号